Dr. Abbey Featured as a Panelist in Retina Times Article on Secondary IOL Placement Surgery
In the Winter 2023 issue of Retina Times published by the American Society of Retina Specialists (ASRS), Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in an article titled, “Managing the
read more
Dr. Abbey Taught a Course at the American Academy of Ophthalmology 2023 Annual Meeting
On November 6, Texas Retina Associates’ Ashkan M. Abbey, MD, taught a continuing medical education (CME) course titled, “Secondary IOL Techniques for Retinal Specialists,” at AAO 2023, the annual meeting of the
read more
Getting to Know Diana Laura, MD
Board-certified ophthalmologist and retina specialist Diana M. Laura, MD, joined Texas Retina Associates in September 2022, and cares for patients in our Dallas Main, Rockwall and Wichita Falls offices. She completed her
read more Dr. Abbey Publishes Case Report on Macular Hole Closure with Intravitreal Dexamethasone Implant
In the September 2023 issue of the peer-reviewed medical journal Ophthalmic Surgery, Lasers and Imaging Retina, Texas Retina’s Ashkan Abbey, MD, describes the use of a dexamethasone intravitreal implant to close a
read more Dr. Abbey Publishes Research on Effectiveness of a Long-acting Injectable Steroid for Patients with Cystoid Macular Edema After Vitrectomy
Long-acting injectable steroids have emerged as a new way to treat chronic intraocular inflammation and cystoid macular edema (CME) that reduces the treatment frequency and burden for retina patients. Texas Retina’s Ashkan
read more Dr. Abbey Presented at the American Society of Retina Specialists 2023 Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, recently presented at the 41st Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) held in Seattle. ASRS is the largest organization of
read more
Dr. Abbey Presents Phase 1 DAVIO Clinical Trial Results to the Association for Research in Vision and Ophthalmology
Dr. Abbey presented the results from the Phase 1 DAVIO trial at ARVO 2023, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO). The trial was a first-in-human
read more Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration
The TRUCKEE study is a real-world, collaborative effort to investigate the efficacy, durability, and safety of a monoclonal antibody treatment called faricimab in patients suffering from neovascular age-related macular degeneration (nAMD) in
read more Dr. Abbey Featured in Retina Times
Texas Retina Associates’ Ashkan Abbey, MD, was featured in the “5 Questions” segment of the latest issue of Retina Today. In the article, he discusses his passion for retina research, what led
read more
Dr. Abbey Featured in New Retina Radio Podcast
Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in a recently released New Retina Radio podcast for retina surgeons titled “Tips for Mastering Secondary IOLs.” Dr. Abbey discussed approaches to implanting
read more